Magecon Lifesciences (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-05-2024
- Paid Up Capital ₹ 0.10 M
as on 24-05-2024
- Company Age 6 Year, 10 Days
- Last Filing with ROC 31 Mar 2019
About Magecon Lifesciences (Opc)
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Somashekhar Malige serves as a director at the Company.
- CIN/LLPIN
U74999KA2018OPC119518
- Company No.
119518
- Incorporation Date
17 Dec 2018
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Magecon Lifesciences (Opc) Private Limited offer?
Magecon Lifesciences (Opc) Private Limited offers a wide range of products and services, including Ayurvedic Joint Pain Relief Medicine, Herbal Joint Pain Relief Tablets, Fairness Cream, Boro Plus Fairness Cream, Dietary Supplements, Flaxseed Oil Capsule.
Who are the key members and board of directors at Magecon Lifesciences (Opc)?
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Somashekhar Malige  | Director | 17-Dec-2018 | Current |
Financial Performance of Magecon Lifesciences (Opc).
Magecon Lifesciences (Opc) Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Magecon Lifesciences (Opc)?
Unlock access to Magecon Lifesciences (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Wedyf International Education Private LimitedActive 6 months 10 days
Somashekhar Malige is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Magecon Lifesciences (Opc)?
Unlock and access historical data on people associated with Magecon Lifesciences (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magecon Lifesciences (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magecon Lifesciences (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
